10 Best Low-Priced Biotech Stocks to Buy Now
On May 8, Michael Yee, Senior Biotech Analyst at Jefferies, appeared on CNBC to discuss how tariffs and policy risks are pressuring the biotech industry, while simultaneously ...
Posts Tagged ‘NASDAQ:IOVA’
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2025 Earnings Call Transcript
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2025 Earnings Call Transcript May 8, 2025Iovance Biotherapeutics, Inc. misses on earnings expectations.
11 Most Promising Penny Stocks According to Analysts
Solus’ Dan Greenhaus, and Invesco's Brian Levitt together appeared on CNBC's 'Closing Bell' on April 15 to talk about tariffs, market uncertainty, and risk concerns.
13 Best Biotech Penny Stocks to Buy According to Hedge Funds
Peter Marks's departure from the FDA has left innovators concerned regarding the current state of the review program at the FDA. Marks had impacts on two key areas.
10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
10 Most Oversold Penny Stocks to Buy According to Analysts
In February 2025, Wellington Management published its outlook for small-cap stocks in 2025.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2024 Earnings Call Transcript
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2024 Earnings Call Transcript February 27, 2025Iovance Biotherapeutics, Inc. reports earnings inline with expectations.
Billionaire Joseph Edelman’s Top 10 Long-Term Stock Picks
Joseph Edelman is a renowned figure in the investment world, recognized for his expertise in biotechnology and healthcare investing.
10 Firms End 2024 Stronger With Impressive Gains
The Dow Jones Industrial Average dipped by 0.07 percent, the S&P 500 shed 0.43 percent, and the Nasdaq Composite declined by 0.90 percent.
10 Most Promising Cancer Stocks According to Hedge Funds
According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for nearly 10 million deaths in 2020, or about one in...
12 NASDAQ Stocks with Biggest Upside Potential According to Analysts
Potomac Wealth Advisors president Mark Avallone joined CNBC's 'The Exchange' on November 16 to discuss where he sees investing opportunities following Trump's election.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2024 Earnings Call Transcript November 7, 2024Iovance Biotherapeutics, Inc. beats earnings expectations.
8 Most Promising Stocks to Buy According to Wall Street Analysts
With only a few days left until the 2024 presidential election, investors are preparing for potential volatility to shake the stock market.
10 Best Biotech Stocks To Buy Under $20
The biotechnology industry is experiencing rapid growth, driven by increasing demand for innovative treatments, technological advancements, and government support.
10 Stocks Under $10 With High Potential
There has been ongoing geopolitical in the Middle East, which escalated recently when Iran launched a series of missiles toward Israel.
10 Worst Cancer Stocks To Buy Now According to Short Sellers
Cancer is the second leading cause of death globally, just behind cardiovascular disease, making oncology one of the largest sectors in the life sciences.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2024 Earnings Call Transcript
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2024 Earnings Call Transcript August 8, 2024Iovance Biotherapeutics, Inc. beats earnings expectations.
Here’s Why Iovance Biotherapeutics (IOVA) Declined in Q2
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
Iovance Biotherapeutics (IOVA) Shares Rallied after the FDA approval of AMTAGVI™
Artisan Partners, an investment management company, released its “Artisan Small Cap Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2024 Earnings Call Transcript
Operator: Welcome to the Iovance Biotherapeutics Conference Call to discuss the First Quarter 2024 Results and recent Corporate Updates.
5 Best Healthcare Stocks to Buy Under $20
In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.
Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks
In this article, we will take a detailed look at Billionaire Paul Tudor Jones and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire...
5 Best Biotech Stocks To Buy Under $20
In this article, we are going to take a closer look at five best biotech stocks to buy under $20.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2023 Earnings Call Transcript
Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.45 EPS, expectations were $-0.44. Iovance Biotherapeutics, Inc.
5 Stocks With Heavy Insider Buying In 2024
This article presents an overview of 5 Stocks With Heavy Insider Buying In 2024. For a detailed overview of such stocks, read our article, 14 Stocks With Heavy Insider Buying...
5 Best Short Squeeze Stocks To Buy Now
In this piece, we will take a look at the five best short squeeze stocks to buy now.
5 Most Promising Cancer Stocks According to Analysts
In this piece, we will take a look at the five most promising cancer stocks according to analysts.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Iovance Biotherapeutics Third Quarter and Year-to-Date 2023 Financial Results and Corporate Update Conference Call.
Should You Exit Iovance Biotherapeutics (IOVA) Following the Recent Uncertainty?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2023 investor letter.
5 Best High Risk High Reward Stocks To Buy Now
In this piece, we will take a look at the five best high risk high reward stocks to buy now.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q2 2023 Earnings Call Transcript
Operator: Welcome to the Iovance Biotherapeutics’ Second Quarter 2023 Financial Results and Corporate Update Conference Call.
5 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 5 stocks with biggest upside potential according to analysts.
5 Best Medical Stocks Under $10
In this piece, we will take a look at the five best medical stocks under $10.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q1 2023 Earnings Call Transcript
Operator: Hello and thank you for standing by. My name is Andrew and I will be your conference operator today.
Should You Hold Iovance Biotherapeutics (IOVA)?
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2022 investor letter.
5 Best Biotech Stocks to Buy Under $20
Biohaven Ltd. (NYSE:BHVN) is an American company headquartered in New Haven, Connecticut.
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) Q4 2022 Earnings Call Transcript
Operator: Welcome to the Iovance Biotherapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call.
12 Stocks Insiders are Buying Now
Investing in stocks that insiders are buying can sometimes lead to unexpected gains.
5 Cheap Small-Cap Stocks to Buy Before the Next Breakout
In this article, we will take a look at the 5 cheap small-cap stocks to buy before the next breakout.
11 Best Very Cheap Stocks To Buy Now According To Hedge Funds
In this article, we discuss the 11 best very cheap stocks to buy according to hedge funds.
Hedge Fund and Insider Trading News: Ken Griffin, Cathie Wood, Kenneth Tropin, Elliott Associates, Tiger Global Management, Coatue Management, Cable One Inc (CABO), Iovance Biotherapeutics, Inc. (IOVA), and More
Tiger Global Management rode the tech boom like no other investment firm. It was funding more startups than any other U.S.
Hedge Fund and Insider Trading News: Ray Dalio, David Tepper, Sanjay Shah, Deerfield Management, Coatue Management, Dicks Sporting Goods Inc (DKS), and More
Like most so-called Tiger Cubs, the tech-focused hedge fund Coatue has lost significant money this year.
Did The Smart Money Get Iovance Biotherapeutics, Inc. (IOVA) Right?
Technology stocks had a lousy start to 2022. QQQ lost 9% of its value in January. Pandemic winners are getting crushed while energy stocks are surging.
Hedge Funds Are Betting On Iovance Biotherapeutics, Inc. (IOVA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Cathie Wood’s ARK Portfolio: Top 5 Losers
In this article, we discuss the 5 biggest losers in the portfolio of Cathie Wood's ARK.
Cathie Wood Portfolio: 10 Biggest Losers
In this article, we discuss the 10 biggest losers in the stock portfolio of Cathie Wood.
Do Hedge Funds Love Iovance Biotherapeutics, Inc. (IOVA)?
At Insider Monkey, we pore over the filings of nearly 873 top investment firms every quarter, a process we have now completed for the latest reporting period.
5 Best Biotech Stocks to Buy According to Joseph Edelman’s Perceptive Advisors
In this article, we will discuss the 5 best biotech stocks to buy according to Joseph Edelman's Perceptive Advisors based on Q2 holdings of the fund.
Artisan Partners Remains ‘Patient’ in Iovance Biotherapeutics (IOVA)
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ second quarter 2021 investor letter – a copy of which can be downloaded...
